FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs

Beckman Coulter’s new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for use in the clinical laboratory.

The small footprint, high precision ‘LOAD & GO’ instrument has been designed specifically for the Lean laboratory, operating 24/7 and requiring automated systems which improve workflow, enhance quality and deliver a consistent turnaround time (TAT). Easy to operate with integrated automated sample preparation like a hematology analyzer, Aquios CL Flow Cytometer delivers first results within 20 minutes for routine applications such as immunophenotyping. Subsequent results are available at a rate of 25 samples per hour for up to a full 96-well plate.

Routine clinical tests such as immunophenotyping can be run in the clinical lab using the new AQUIOS CL flow cytometer from Beckman Coulter Life Sciences

Routine clinical tests such as immunophenotyping can be run in the clinical lab using the new AQUIOS CL flow cytometer from Beckman Coulter Life Sciences

Mario Koksch, Vice President and General Manager of Beckman Coulter’s Cytometry Business Unit explained: “The AQUIOS CL Flow Cytometer technology transforms the way routine applications such as immunophenotyping are managed by the clinical lab. The precision of the AQUIOS CL Flow Cytometer in establishing the lymphocyte gate makes it possible to carry out high volume, T, B, and NK cell analysis within the hospital lab instead of an external lab.

“The high level of automation helps prevent sample processing errors and frees up experienced staff for more complex analysis, making better use of staff resources.  In addition, by removing manual processes, the instrument delivers operational savings and increases overall workflow.”

FDA clears AQUIOS CL Clinical Flow Cytometer /Page 2 of 2

Once samples are loaded, the instrument automatically carries out mixing, cap piercing, sample preparation, and analysis. Its automated cap-piercing technology helps reduce staff exposure to biohazardous samples. Dr Koksch added: “Today’s Lean laboratory requires instrumentation that also offers staff safety features alongside efficiency and lower costs.”

The fully integrated system includes a 40-tube capacity autoloader able to handle a variety of tube sizes, with continuous, random loading and unloading.  There is a separate single-tube loader for STAT samples. Sample preparation, reagent monitoring, barcode scanning and LIS connectivity are all automated.

Intuitive software also makes the system fast and easy to use.  ‘SmartTrack reagent monitoring’ tracks reagent use and test progress, with barcode tracking eliminating manual quality control and reagent logs.  If the QC fails, the system automatically alerts the operator by text message or email for intervention.

The first tests available are Tetra-1 (CD45/4/8/3), Tetra-2+ (CD45/56+16/19/3), and Tetra Combo (both Tetra-1 and -2+) for immune status monitoring.  For the Tetra application, the first result is available in approximately 20 minutes from loading (measured with Tetra-1 or Tetra-2+), with subsequent results delivered at the rate of 25 samples per hour, for up to a full 96 well plate (measured with Tetra Combo).

For more information, please visit www.beckmancoulter.com and www.AQUIOScl.com/us/

Beckman Coulter, AQUIOS, Load & Go, and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered with the USPTO.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Beckman Coulter Life Sciences - Flow Cytometry. (2017, July 12). FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs. News-Medical. Retrieved on December 13, 2019 from https://www.news-medical.net/news/20150505/FDA-clears-AQUIOS-CL-Flow-Cytometer-for-routine-immunophenotyping-applications-in-US-clinical-labs.aspx.

  • MLA

    Beckman Coulter Life Sciences - Flow Cytometry. "FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs". News-Medical. 13 December 2019. <https://www.news-medical.net/news/20150505/FDA-clears-AQUIOS-CL-Flow-Cytometer-for-routine-immunophenotyping-applications-in-US-clinical-labs.aspx>.

  • Chicago

    Beckman Coulter Life Sciences - Flow Cytometry. "FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs". News-Medical. https://www.news-medical.net/news/20150505/FDA-clears-AQUIOS-CL-Flow-Cytometer-for-routine-immunophenotyping-applications-in-US-clinical-labs.aspx. (accessed December 13, 2019).

  • Harvard

    Beckman Coulter Life Sciences - Flow Cytometry. 2017. FDA clears AQUIOS CL Flow Cytometer for routine immunophenotyping applications in US clinical labs. News-Medical, viewed 13 December 2019, https://www.news-medical.net/news/20150505/FDA-clears-AQUIOS-CL-Flow-Cytometer-for-routine-immunophenotyping-applications-in-US-clinical-labs.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Beckman Coulter Life Sciences introduces free online DURA Innovations calculator tool